DocGo Inc. (NASDAQ:DCGO – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $4.89.
DCGO has been the topic of several recent research reports. Stifel Nicolaus decreased their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $5.00 to $2.85 in a research note on Friday, February 28th. Finally, Needham & Company LLC cut their price target on DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a report on Friday, February 28th.
Check Out Our Latest Analysis on DocGo
DocGo Trading Up 3.7 %
Institutional Trading of DocGo
A number of hedge funds and other institutional investors have recently modified their holdings of DCGO. Centiva Capital LP purchased a new position in shares of DocGo during the 3rd quarter valued at $43,000. Summit Investment Advisors Inc. raised its holdings in DocGo by 38.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after acquiring an additional 2,968 shares during the period. Prudential Financial Inc. purchased a new position in shares of DocGo in the fourth quarter valued at about $55,000. Intech Investment Management LLC bought a new position in shares of DocGo in the third quarter worth about $62,000. Finally, Royce & Associates LP purchased a new stake in shares of DocGo during the fourth quarter worth about $64,000. 56.44% of the stock is owned by hedge funds and other institutional investors.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Read More
- Five stocks we like better than DocGo
- Why is the Ex-Dividend Date Significant to Investors?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Stock Dividend Cuts Happen Are You Ready?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.